Evidence map›Paper›PMID 22530015›Full record

ArticlePloS one2012

Inhibition of diacylglycerol-sensitive TRPC channels by synthetic and natural steroids.

Susanne Miehe, Peter Crause, Thorsten Schmidt, Matthias Löhn, Heinz-Werner Kleemann, Thomas Licher, Werner Dittrich, Hartmut Rütten, Carsten Strübing

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Activation of TRPV4 channels leads to a consistent tocolytic effect on human myometrial tissues.European journal of obstetrics & gynecology and reproductive biology: X · 2021
    Article
  7. Review
  8. Article
  9. Article
  10. In vivo selective inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal disease.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  11. Review
  12. Article
  13. Ryanodine and IPNeurophotonics · 2017
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Susanne MieheSanofi-Aventis Deutschland GmbH, Research and Development, Frankfurt am Main, Germany.
Peter Crause
Thorsten Schmidt
Matthias Löhn
Heinz-Werner Kleemann
Thomas Licher
Werner Dittrich
Hartmut Rütten
Carsten Strübing
Sanofi (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TRPC channels are a family of nonselective cation channels that regulate ion homeostasis and intracellular Ca(2+) signaling in numerous cell types. Important physiological functions such as vasoregulation, neuronal growth, and pheromone recognition have been assigned to this class of ion channels. Despite their physiological relevance, few selective pharmacological tools are available to study TRPC channel function. We, therefore, screened a selection of pharmacologically active compounds for TRPC modulating activity. We found that the synthetic gestagen norgestimate inhibited diacylglycerol-sensitive TRPC3 and TRPC6 with IC(50)s of 3-5 µM, while half-maximal inhibition of TRPC5 required significantly higher compound concentrations (>10 µM). Norgestimate blocked TRPC-mediated vasopressin-induced cation currents in A7r5 smooth muscle cells and caused vasorelaxation of isolated rat aorta, indicating that norgestimate could be an interesting tool for the investigation of TRP channel function in native cells and tissues. The steroid hormone progesterone, which is structurally related to norgestimate, also inhibited TRPC channel activity with IC(50)s ranging from 6 to 18 µM but showed little subtype selectivity. Thus, TRPC channel inhibition by high gestational levels of progesterone may contribute to the physiological decrease of uterine contractility and immunosuppression during pregnancy.

Indexed as

AnimalsAorta, ThoracicCalciumDiglyceridesHumansMaleMyocytes, Smooth MuscleNorgestrelProgesteroneRatsRats, WistarReceptors, VasopressinSteroidsTRPC6 Cation ChannelTRPC Cation ChannelsVasopressinsCalciumDiglyceridesnorgestimateNorgestrelProgesteroneReceptors, VasopressinSteroidsTRPC3 cation channelTRPC6 Cation ChannelTRPC6 protein, humanTRPC Cation ChannelsVasopressins

Identifiers

PMID22530015
PMCPMC3328449
OpenAlexW2025477007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.